KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Depreciation and Depletion (2018 - 2019)

ClearPoint Neuro (CLPT) has disclosed Depreciation and Depletion for 2 consecutive years, with $35710.0 as the latest value for Q3 2019.

  • Quarterly Depreciation and Depletion rose 38.48% to $35710.0 in Q3 2019 from the year-ago period, while the trailing twelve-month figure was $131098.0 through Sep 2019, changed N/A year-over-year, with the annual reading at $400000.0 for FY2025, 100.0% up from the prior year.
  • Depreciation and Depletion hit $35710.0 in Q3 2019 for ClearPoint Neuro, up from $34960.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $35710.0 in Q3 2019 to a low of $23795.0 in Q2 2018.